B-Cell Lymphoma Producing IgM Anti-B Antibody: A Case Report
- PMID: 35652068
- PMCID: PMC9150775
- DOI: 10.3389/fmed.2022.904296
B-Cell Lymphoma Producing IgM Anti-B Antibody: A Case Report
Abstract
ABO blood group system is the most important blood group system in transfusion and transplantation medicine. Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphomas (NHLs) worldwide. There have been some studies that lymphoma could affect ABO blood group system and thus affect blood transfusion strategy. However, the mechanisms lymphoma affecting ABO blood group system have not been fully elucidated so far. Here, we report a case of a patient who was a 72-year-old Chinese man came to our hospital for medical advice because of cervical lymphadenophathy. The patient was subsequently diagnosed with diffuse large B-cell lymphoma by lymph-node biopsy. His ABO blood group was initially typed as B on November 7, 2020. He was transfusing B type leukocyte poor RBCs (LPR) before we found the patient's ABO blood group discrepancy on December 2, 2020 by forward and reverse typing methods, which the discrepancy was verified by genotyping. The patient began to transfuse O type washed RBCs (WRBC) since then. Compared to transfuse B type leukocyte poor RBCs (LPR), the efficiency of transfusing O type washed RBCs (WRBC) was better. Although hemoglobin level did not greatly improve, indirect bilirubin level evidently decreased. Furthermore, we found B-cell lymphoma affected blood transfusion strategy by producing IgM anti-B antibody in this case. Clinicians should need to be aware of the effect of B-cell lymphoma on blood transfusion strategy.
Keywords: ABO blood group discrepancy; B-cell lymphoma; case report; genotyping; serology.
Copyright © 2022 Jiang, Song, Wang and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Blood group discrepancy in Ah para-Bombay phenotype: a rare blood group variant and its clinical significance.Immunohematology. 2021;37(4):160-164. doi: 10.21307/immunohematology-2021-026. Immunohematology. 2021. PMID: 34964314
-
[Rare blood group B (A) detection and safe transfusion].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1280-4. doi: 10.7534/j.issn.1009-2137.2013.05.039. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24156450 Chinese.
-
Case report of anti-f(ce) antibody identified with unknown autoantibody from ABO discrepancy in a patient with liver cell carcinoma.Transfus Apher Sci. 2025 Feb;64(1):104046. doi: 10.1016/j.transci.2024.104046. Epub 2024 Dec 12. Transfus Apher Sci. 2025. PMID: 39700841
-
Detection of anti-B antibodies in a patient with A1B blood group: A case report and literature review.Transfus Apher Sci. 2022 Oct;61(5):103450. doi: 10.1016/j.transci.2022.103450. Epub 2022 Apr 20. Transfus Apher Sci. 2022. PMID: 35469752 Review.
-
Neonatal testing leading to the identification of Bh (para-Bombay) phenotype in the mother: case report with review of the literature.Immunohematology. 2021 Jun;37(2):59-63. doi: 10.21307/immunohematology-2021-008. Immunohematology. 2021. PMID: 34170641 Review.
References
Publication types
LinkOut - more resources
Full Text Sources